NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

價值為基礎醫療 (Value Based Care):現狀分析與未來預測 (2021年∼2027年)

Value-Based Care Market: Current Analysis and Forecast (2021-2027)

出版商 UnivDatos Market Insights Pvt Ltd 商品編碼 1008379
出版日期 內容資訊 英文 237 Pages
商品交期: 最快1-2個工作天內
價格
價值為基礎醫療 (Value Based Care):現狀分析與未來預測 (2021年∼2027年) Value-Based Care Market: Current Analysis and Forecast (2021-2027)
出版日期: 2021年05月31日內容資訊: 英文 237 Pages
簡介

所謂價值為基礎醫療 (VBC: Value Based Care) ,是依據患者的健康狀態和所接受的服務的品質,對醫院、研究室、醫生、護士等醫療提供者,支付獎勵的醫療提供計劃。這些模型將提供者、保險公司、付款人和患者聯繫在一起,並以顯著的方式使每個人受益,同時降低醫療保健成本,這就是為什麼VBC市場有望在預測期內蓬勃發展的原因。

各模式中,隨著ACO (責任制醫療組織)增加,獲得大幅市場佔有率。各部署方式中,雲端方式成為主體。各終端用戶中,醫療提供者部門大幅成長。各地區中,北美各國有最大的市場,市場成長率的亞太地區最大。

本報告提供全球價值為基礎醫療 (Value Based Care)的市場相關分析,市場概要和背景情況、相關法規,市場基本結構和最新形勢,主要的促進、阻礙因素,整體市場規模趨勢預測 (2021∼2027年),各市場區隔 (各模式、各部署方式、各平台、各終端用戶)、各地區的詳細趨勢,市場競爭狀態,主要企業的簡介,新型冠狀病毒感染疾病 (COVID-19)的影響等調查。

目錄

第1章 分析概要

第2章 分析方法與前提條件

第3章 市場概要

第4章 摘要整理

第5章 價值為基礎醫療 (Value Based Care) 領域主要的Start-Ups企業

第6章 全球價值為基礎醫療 (Value Based Care) 市場:COVID-19的影響

第7章 全球價值為基礎醫療 (Value Based Care)的市場收益額 (以金額為準,2019年∼2027年)

第8章 各模式的市場分析

  • ACO (責任制醫療組織)
  • PCMH (患者中心的醫療設施)
  • P4P (業績為基礎支付方式)
  • 捆綁式付款

第9章 各部署方式的市場分析

  • 雲端基礎
  • 內部部署

第10章 各平台的市場分析

  • 獨立式
  • 整合型

第11章 各終端用戶市場洞察

  • 醫療提供者
  • 付款者
  • 患者

第12章 各地區的市場洞察

  • 北美市場
    • 美國
    • 加拿大
    • 北美
  • 歐洲市場
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他的歐洲各國
  • 亞太地區市場
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他的亞太地區各國
  • 其他的國家 (RoW)的市場

第13章 價值為基礎醫療 (Value Based Care)的市場動態

  • 市場促進因素
  • 市場課題
  • 影響分析

第14章 價值為基礎醫療 (Value Based Care) 市場機會

第15章 價值為基礎醫療 (Value Based Care) 市場趨勢

第16章 法規、法規結構

第17章 需求/供給側面分析

  • 需求方面分析
  • 供給側面分析
    • 主要產品的銷售
    • 主要企業聯盟
    • 主要企業擴大、投資、資產出售
    • 主要的企業合併、收購 (M&A)

第18章 價值鏈分析

第19章 競爭模式

  • 波特的五力分析
  • 競爭情形
    • 市場收益額佔有率:各企業

第20章 企業概要

  • Siemens Healthineers
  • Nextstep Solutions
  • Athena Health
  • NXGN Management, LLC
  • McKesson Corporation
  • Optum
  • Oliver Wyman
  • Baker Tilly
  • Aetna
  • Blue Cross Blue Shield Association

第21章 免責聲明

目錄
Product Code: UMHE21235

In medicare industry the Value-based care models are seeking interest of many investors in recent times. These models connects the providers, insurers, payers, and patients together and benefits everyone in a significant manner along with lowering the healthcare costs which is why the market for VBC is expected to thrive in the forecast period. For instance, "Deloitte", center for Health Solutions in 2019, reported some significant investments which has done by the payers and other stakeholders for the implementation of value-based care initiatives. These investment include:

Blue Cross Blue Shield health spend more than USD 65 million annually or about 20% of their spending on medical claims, on VBC

The Department of Health & Human Services, has spend 30% of payments on traditional medicare benefits to value-based payment models at the end of 2016 and had reached up to 50% in 2018

"Aetna" devoted 15% of its 2013 spending on value-based care efforts and reached at the amount to 45% in 2017

Value-Based Care is a health care delivery plan under which providers like hospitals, labs, doctors, nurses and others are paid based on the health results of their patients and the quality of services provided. Providers shares some financial risk with health insurance companies under some value-based contracts where in addition to negotiated payments, they earn incentives for providing high-quality and efficient care. VBC varies from the traditional fee-for-service plan where providers are paid distinctly for each medical services. Although, quality care is provided under both models, the main difference is how providers are paid, connected with patient and care is managed, that only offers in a VBC surroundings by providing healthcare enhancements and cost savings

The main objective driving the implementation of value-based healthcare is concentrated on "quality", organizations have seen profits that extend to operations and reduced costs. For instance, in February 2019 health services provider "Cigna" announced that 3.6 million patients receiving care through a value-based model which interprets, they exceeded their goal by 50% of its payments. This move helped to save "Cigna" more than USD 600 million between 2013 and 2017, and the company highlighted data analytics and value-based care as a critical element of their success

Due to the impact of the Covid-19, the National Association of Accountable Care Organizations (NAACOS) surveyed the ACO community to measure their experience in handling the ongoing pandemic. As a result, More than half, 56%, of healthcare organizations said that they were taking financial risk in a Medicare program proven to lower the cost of care and they likely to drop out the program because of the fear to pay massive losses resulting from the COVID-19 pandemic. But almost 20% of Medicare beneficiaries and nearly 500,000 clinicians' practice in an ACO in 2020, making the shared Savings Program the largest value-based payment model in Medicare

Based on the models, the market is bifurcated into Accountable Care Organization (ACO), Patient-Centered Medical Home (PCMH), Pay for Performance (P4P), and bundled payments. The Accountable Care Organization (ACO) segment grabbed the major market as the quantity of Accountable Care Organizations (ACO) is expanding, by inserting more protection and security. For instance, according to the Journal of Health Affairs 2018, almost 1,000 ACOs spread across the USA in 2017, which represented more than 1,400 contracts with commercial and government insurers wrapping more than 32 million Americans. These models are easy to use and offers healthcare at low costs increases its demand in the market

Based on deployment, the market is fragmented into cloud-based and on-premises. The cloud-based segment accounted for the major revenue portion in 2020. As, the Companies such as Qualcomm Life Inc., Opzoon Technology Co., Ltd., and Fibocom Wireless Inc. are involved in the sales of wireless and cloud-based technology products used in the healthcare industry

Based on platform, the market is fragmented into standalone and integrated. The integrated platform segment accounted for the major revenue portion in 2020. The sector is anticipated to observe significant growth in the upcoming years as by working in integration the organizations might produce more profits. When payers and other stakeholders make significant investments, they produce additional profits in value-based models

Based on end-user, the market is fragmented into providers, payers, and patients. The providers segment is anticipated to observe lucrative growth. As providers are not only concentrating on growing their infrastructure but also trying to improve it. So, that Patients can get easy access to healthcare facilities and cost reduction.

For a better understanding of the market adoption of the value-based cares, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of APAC), and Rest of World. North America constitutes a major market for the value-based care industry and generated revenue of USD XX million in 2020 owing to the presence of key companies and advanced healthcare infrastructure with highest spending's in healthcare. However, the Asia Pacific region would grow at the highest CAGR during the forecast period

Some of the major players operating in the market include Siemens Healthineers , Nextstep Solutions, Athena Health, NXGN Management, LLC, McKesson Corporation, Optum, Oliver Wyman, Baker Tilly, Aetna, Blue Cross Blue Shield Association, etc. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions

The global value-based care market was valued at USD XX million in 2020 and is projected to expand significantly with a CAGR of XX% from 2021F-2027F. The global value-based care market is expected to witness a boost as it provides better healthcare outcomes at lower costs. The key players worldwide are introducing advanced shared savings programs to cater middle-income groups to boost the growth of the value-based care market.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 Market Definitions
  • 1.2 Objective of the Study
  • 1.3 Limitation
  • 1.4 Stake Holders
  • 1.5 Currency Used in Report
  • 1.6 Scope of the Global Value Based Care Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1 Research Methodology for the Global Value Based Care Market
    • 2.1.1 Main Objective of the Global Value Based Care Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPS UNDER VALUE BASED CARE SECTOR

6 GLOBAL VALUE BASED CARE AMID COVID-19

7 GLOBAL VALUE BASED CARE MARKET REVENUE (USD BN), 2019-2027F

8 MARKET INSIGHTS BY MODELS

  • 8.1 Accountable Care Organization (ACO)
  • 8.2 Patient-Centered Medical Home (PCMH)
  • 8.3 Pay for Performance (P4P)
  • 8.4 Bundled Payments

9 MARKET INSIGHTS BY DEPLOYMENT

  • 9.1 Cloud Based
  • 9.2 On-Premises

10 MARKET INSIGHTS BY PLATFORM

  • 10.1 Standalone
  • 10.2 Integrated

11 MARKET INSIGHTS BY END-USER

  • 11.1 Providers
  • 11.2 Payers
  • 11.3 Patients

12 MARKET INSIGHTS BY REGION

  • 12.1 North America Value Based Care Market
    • 12.1.1 United States
    • 12.1.2 Canada
    • 12.1.3 Rest of North America
  • 12.2 Europe Value Based Care Market
    • 12.2.1 Germany
    • 12.2.2 France
    • 12.2.3 United Kingdom
    • 12.2.4 Italy
    • 12.2.5 Spain
    • 12.2.6 Rest of Europe
  • 12.3 Asia Pacific Value Based Care Market
    • 12.3.1 China
    • 12.3.2 Japan
    • 12.3.3 India
    • 12.3.4 Australia
    • 12.3.5 Rest of Asia Pacific
  • 12.4 Rest of World Value Based Care Market

13 VALUE BASED CARE MARKET DYNAMICS

  • 13.1 Market Drivers
  • 13.2 Market Challenges
  • 13.3 Impact Analysis

14 VALUE BASED CARE MARKET OPPORTUNITIES

15 VALUE BASED CARE MARKET TRENDS

16 LEGAL & REGULATORY FRAMEWORK

17 DEMAND AND SUPPLY SIDE ANALYSIS

  • 17.1 Demand Side Analysis
  • 17.2 Supply Side Analysis
    • 17.2.1 Top Product Launches
    • 17.2.2 Top Business Partnerships
    • 17.2.3 Top Business Expansions, Investments and Divestitures
    • 17.2.4 Top Merger and Acquisitions

18 VALUE CHAIN ANALYSIS

19 COMPETITIVE SCENARIO

  • 19.1 Porter's Five Forces Analysis
    • 19.1.1 Bargaining power of Supplier
    • 19.1.2 Bargaining power of Buyer
    • 19.1.3 Industry Rivalry
    • 19.1.4 Availability of Substitute
    • 19.1.5 Threat of new Entrants
  • 19.2 Competitive Landscape
    • 19.2.1 Company Shares, By Revenue

20 COMPANY PROFILED

  • 20.1 Siemens Healthineers
  • 20.2 Nextstep Solutions
  • 20.3 Athena Health
  • 20.4 NXGN Management, LLC
  • 20.5 McKesson Corporation
  • 20.6 Optum
  • 20.7 Oliver Wyman
  • 20.8 Baker Tilly
  • 20.9 Aetna
  • 20.10 Blue Cross Blue Shield Association

21 DISCLAIMER